|
WO2011105902A2
|
|
Antagonists of complement component 8-beta (c8-beta) and uses thereof
|
|
WO2011105901A2
|
|
Antagonists of complement component 9 (c9) and uses thereof
|
|
WO2011105900A2
|
|
Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
|
|
WO2012047093A1
|
|
Treatment of the sjögren's syndrome
|
|
WO2010123357A1
|
|
Differentiated human liver cell cultures and their use in bioartificial liver systems
|
|
WO2011049433A1
|
|
Diagnosis and treatment of pruritis
|
|
WO2010027264A1
|
|
Hangover relief by compositions comprising oral rehydration solution
|
|
WO2009045104A1
|
|
Method for diagnosing presymptomatic organ transplant rejection
|
|
EP2191018A2
|
|
Pathways involved in arteriogenesis and uses thereof
|
|
WO2008075957A1
|
|
Treatment of fabry disease
|
|
US2010047844A1
|
|
Diagnostic marker for fabry disease
|
|
EP2088854A1
|
|
Improved xenogenic immune system in a non-human mammal
|
|
KR20070057712A
|
|
New method of treatment for non alcoholic steatotic hepariris(nash)
|
|
WO2005087264A1
|
|
Cd44-targeting for reducing/preventing ischemia-reperfusion-injury
|
|
WO2005039578A2
|
|
Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
|
|
US7632654B2
|
|
Means and methods for detecting endoglycosidase activity
|
|
WO2005034984A1
|
|
Cd44 splice variant in diagnosis and therapy of intestinal cancer
|
|
WO2004111647A1
|
|
Analysis of a microarray data set
|
|
AU2003290461A1
|
|
Polymorhisms in the dihydropyrimidase gene
|
|
AU2003286976A1
|
|
Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells
|
